Skip to content
Unrated Drug recall · FDA · Published December 21, 2023

Insight Pharmaceuticals recalls Americaine benzocaine spray due to benzene contamination

Insight Pharmaceuticals recalls Americaine benzocaine topical anesthetic spray (2 oz) due to benzene contamination. Affected products have NDC 63736-378-02 and were made in India with specific lot numbers.

🇺🇸 FDA recall #D-0236-2024DrugInsight Pharmaceuticals ›
Take action

Contact the company

Recalling firmInsight Pharmaceuticals LLC, a Prestige Consumer Healthcare company660 White Plains Rd Ste 250 · Tarrytown, NY 10591-5171
✎ GovInfoNow plain-language explainer

Insight Pharmaceuticals is recalling Americaine benzocaine topical anesthetic spray because it contains benzene, a known chemical contaminant. This poses a risk of harm to users, especially those with sensitive skin or respiratory issues. Read more at govinfonow.com/recall/32920-insight-pharmaceuticals-recalls-americaine-benzocaine-spray-due-to-benzene-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/32920-insight-pharmaceuticals-recalls-americaine-benzocaine-spray-due-to-benzene-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0236-2024

Cite this page

“Insight Pharmaceuticals recalls Americaine benzocaine spray due to benzene contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32920-insight-pharmaceuticals-recalls-americaine-benzocaine-spray-due-to-benzene-contamination. Based on FDA recall #D-0236-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0236-2024%22&limit=1).

The FDA announced on Dec. 21, 2023, that Insight Pharmaceuticals LLC recalled Americaine Benzocaine Topical Anesthetic Spray due to benzene contamination. The agency classified the Class I recall as voluntary and completed.

How to tell if you have it

  • Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G)
  • NDC 63736-378-02
  • Can UPC 3 63736 37882 0
  • Case UPC 1 03 63736 37882 7
  • Lot # 1A16420
  • Exp. date 01/31/2025

The hazard

The recall addresses the presence of benzene in the product, which poses a chemical contamination hazard. The FDA classified this as a Class I recall, indicating a situation where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death.

Context

GovInfoNow's records show Insight Pharmaceuticals LLC has two other recalls on record since Feb. 1, 2024. Other recent recalls of similar products include Sandra Lee MD Acne Spot Treatment Recall (March 3, 2026), Owen Biosciences Night Lotion Recall (March 3, 2026), and Owen Biosciences Recalls Acne Lotion with Benzene Contamination (March 3, 2026).

How to tell if you have this one

Check for the NDC code 63736-378-02 on the product label. The spray was made in India with lot number 1A16420 and expires January 31, 2025.

  • Brand
    Insight Pharmaceuticals
  • Product
    Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC code 63736-378-02 and lot number 1A16420 on the spray can.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 34 days after the firm started it.

1. Firm started the recall: Dec 21, 202312. FDA classified it Class I: Jan 17, 202423. Published in FDA’s Enforcement Report: Jan 24, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Insight Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0236-2024 (December 21, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0236-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA